Crinetics Pharmaceuticals, Inc. CRNX
$83.52
-0.13%
at last close
Financials (TTM)
- Revenue
- $18.07 million
- Net Income
- $-496,388,000
- Net Margin
- -2747.18%
- Return on Equity
- -38.76%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 6.91
- Price / Sales
- 489.87
Over the trailing twelve months, Crinetics Pharmaceuticals, Inc. generated revenue of $18.07 million and net income of $-496,388,000, a net margin of -2747.18%.
At the last closing price of $83.52, CRNX trades at 489.87 times sales, with a market capitalization of $8.85 billion.
Key Stats
- Last Close
- $83.52
- Market Cap
- $8.85 billion
- 52-Week Range
- $25.83 – $84.00
- Average Volume
- 6.45 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.